Trial intelligence / Profile preview

IST vs IPTp for Malaria in Pregnancy

NCT00432367Phase 3Completed

Sponsor
London School of Hygiene & Tropical Medicine
Start
Feb 2007
Primary completion
Feb 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of artesunate + amodiaquine in malaria (3 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Prevalence of severe maternal anaemia (Hb < 8g/dl). Started Feb 2007; status: completed.

02

Drugs

artesunate + amodiaquine
03

Conditions

malaria

Beyond the preview

Go deeper on NCT00432367.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00432367.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call